Slough, UK, and Richmond, VA, January 15, 2021 – The Group is providing the below preliminary unaudited financial results based on current financial information for the year ended December 31, 2020.
Total net revenue is now expected to be in the range of $645m to $650m (guidance $595m to $620m) due to:
- Expected SUBLOCADE® net revenue between $128m to $130m (guidance of $120m to $125m), which represents preliminary Q4 2020 SUBLOCADE® net revenue growth of 12% to 18% versus Q3 2020 reported SUBLOCADE® net revenue of $33m;
- The relative resilience of SUBOXONE® Film share through the end of FY 2020 as well as benefits from modest stocking activity in the U.S. in the fourth quarter; and,
- Expected PERSERIS® net revenue consistent with guidance of $12m to $15m.
An operating expense base (SG&A and R&D combined) that is expected to be slightly below guidance of $470m to $480m.
Based on these preliminary results, the Group now expects to deliver adjusted pre-tax income ahead of its previous expectations.
Indivior expects to report FY 2020 results on February 18, 2021.
About Indivior
Indivior is a global pharmaceutical company working to help change patients’ lives by developing medicines to treat addiction and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease.
Building on its global portfolio of opioid dependence treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 700 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior.
Share